Clostridium difficile--beyond antibiotics.
Kyne
Lorraine
L
D000906:Antibodies / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000992:Antitoxins / Q000627:therapeutic use*; D001426:Bacterial Proteins / Q000037:antagonists & inhibitors / Q000276:immunology*; D001427:Bacterial Toxins / Q000037:antagonists & inhibitors / Q000276:immunology*; D016360:Clostridioides difficile; D003015:Clostridium Infections / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D004768:Enterotoxins / Q000037:antagonists & inhibitors / Q000276:immunology*; D006801:Humans; D055502:Secondary Prevention
D000906:Antibodies; D000911:Antibodies, Monoclonal; D000992:Antitoxins; D001426:Bacterial Proteins; D001427:Bacterial Toxins; D004768:Enterotoxins; C041348:tcdA protein, Clostridium difficile; C031815:toxB protein, Clostridium difficile